Healthcare >> CEO Interviews >> April 2, 2015

Interview with the Scientific Founder, President and CEO: Concert Pharmaceuticals, Inc. (CNCE)

Roger D. Tung
Roger D. Tung, Ph.D., is the Scientific Founder of Concert Pharmaceuticals, Inc., and has served as its President, Chief Executive Officer and a member of its board of directors since its incorporation in April 2006. Before Concert, Dr. Tung was a founding scientist at Vertex, a pharmaceutical company where he was employed from 1989 to 2005, most recently as its Vice President of Drug Discovery. Prior to Vertex, he held various positions at Merck Sharp & Dohme Research Laboratories, a global health care provider, and The Squibb Institute for Medicinal Chemistry. Dr. Tung received a B.A. in chemistry from Reed College and a Ph.D. in medicinal chemistry at the University of Wisconsin-Madison. Profile
TWST: Let’s start with Concert Pharmaceuticals’ background, its historical beginnings and what led up to its IPO in 2014.

Dr. Tung: Concert’s history is that it came